Aureus Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Aureus Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,820	Closed	-$204K	–	236
2021 Q4	$204K	Hold	1,820	–	–	0.01%	201
2021 Q3	$229K	Hold	1,820	–	–	0.02%	191
2021 Q2	$246K	Hold	1,820	–	–	0.02%	196
2021 Q1	$247K	Hold	1,820	–	–	0.02%	158
2020 Q4	$256K	Hold	1,820	–	–	0.02%	162
2020 Q3	$203K	Hold	1,820	–	–	0.02%	170
2020 Q2	$204K	Buy	+1,820	New	+$179K	0.02%	160
2020 Q1	–	Sell	-2,910	Closed	-$277K	–	178
2019 Q4	$277K	Hold	2,910	–	–	0.03%	151
2019 Q3	$222K	Hold	2,910	–	–	0.03%	157
2019 Q2	$255K	Hold	2,910	–	–	0.03%	156
2019 Q1	$263K	Hold	2,910	–	–	0.03%	148
2018 Q4	$209K	Hold	2,910	–	–	0.03%	159
2018 Q3	$279K	Hold	2,910	–	–	0.04%	157
2018 Q2	$277K	Hold	2,910	–	–	0.04%	159
2018 Q1	$255K	Hold	2,910	–	–	0.04%	155
2017 Q4	$247K	Hold	2,910	–	–	0.04%	160
2017 Q3	$252K	Hold	2,910	–	–	0.04%	158
2017 Q2	$225K	Hold	2,910	–	–	0.04%	149
2017 Q1	$201K	Buy	+2,910	New	+$195K	0.03%	178
2016 Q1	–	Sell	-2,910	Closed	-$204K	–	149
2015 Q4	$204K	Buy	+2,910	New	+$198K	0.05%	139
2015 Q3	–	Sell	-2,910	Closed	-$245K	–	176
2015 Q2	$245K	Hold	2,910	–	–	0.05%	145
2015 Q1	$219K	Buy	+2,910	New	+$203K	0.05%	138

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Aureus Asset Management's XBI Position: Q1 2022 in Review

Aureus Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 1,820 shares — an estimated $204K sold.

Aureus Asset Management first reported a position in XBI in Q1 2015 and held it in 22 quarters. The position peaked at $279K in Q3 2018. 702 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Aureus Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Aureus Asset Management sold 1,820 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $204K.
Aureus Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 22 quarters.
Aureus Asset Management's State Street SPDR S&P Biotech ETF position peaked at $279K in Q3 2018.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Aureus Asset Management's 13F filing for Q1 2022, filed 12 May 2022.